In addition, sPD-1, retaining the function proper of full-length PD-1, is able to engage with membrane-bound ligands and enhance T cell-dependent anti-tumor immune responses limiting the binding of PD-1+ cells with PD-Ls+ neoplastic cells. The gene discussed is PDCD1; the disease is neoplasm.